Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
1.
Br J Oral Maxillofac Surg ; 59(10): 1280-1286, 2021 12.
Article in English | MEDLINE | ID: mdl-34465487

ABSTRACT

Merkel cell carcinoma (MCC) is a rare and highly aggressive neuroendocrine malignancy of the skin. Its incidence is increasing with half of cases involving the head and neck. To the best of our knowledge, few large studies have been published in the UK, and to date this is the largest reported series of head and neck MCC. We retrospectively reviewed the outcomes of patients with MCC in three hospitals in the south-east of England over a 12-year period (2008-2019). Diagnosis was based on histological data following biopsy. Overall survival and disease-specific survival were calculated using Kaplan-Meier and log-rank tests. Fifty-eight patients met the inclusion criteria (24 stage I, 22 stage II, 9 stage III, and 3 unclassified). Median disease-free survival was 36 months (95% CI 0 to 77.2) and median overall survival 50 months (95% CI 29.9 to 70). Overall five-year survival was 34.4% (95% CI 17% to 52%) with two-year survival at 62% (95% CI 48% to 76%). Five-year disease-free survival was 26.7% (95% CI 17 to 52%) with two-year disease-free survival at 54% (95% CI 40% to 68%). To date, this is the largest UK based study reporting overall and disease-free survival associated with MCC of the head and neck. Half the patients presented late, and surgery was the mainstay of treatment, augmented by adjuvant radiotherapy. There is a need to better stratify patients at risk of developing metastatic disease, with the use of sentinel lymph node biopsy and positron-emission tomography-computed tomography (PET-CT), as immunotherapy and targeted agents are now available to treat advanced disease.


Subject(s)
Carcinoma, Merkel Cell , Skin Neoplasms , Humans , Neoplasm Staging , Positron Emission Tomography Computed Tomography , Retrospective Studies , Sentinel Lymph Node Biopsy
2.
Article in English | MEDLINE | ID: mdl-18252365

ABSTRACT

We consider a fundamental inference problem in syntactic pattern recognition (PR). We assume that the system has a dictionary which is a collection of all the ideal representations of the objects in question. To recognize a noisy sample, the system compares it with every element in the dictionary based on a nearest-neighbor philosophy, using three standard edit operations: substitution, insertion, and deletion, and the associated primitive elementary edit distances d(.,.). In this paper, we consider the assignment of the inter-symbol distances using the parametric distances. We show how the classifier can be trained to get the optimal parametric distance using vector quantization in the meta-space. In all our experiments, the training was typically achieved in a very few iterations. The subsequent classification accuracy we obtained using this single-parameter scheme was 96.13%. The power of the scheme is evident if we compare it to 96.67%, which is the accuracy of the scheme which uses the complete array of inter-symbol distances derived from a knowledge of all the confusion probabilities.

3.
J Med Virol ; 31(2): 109-11, 1990 Jun.
Article in English | MEDLINE | ID: mdl-2143776

ABSTRACT

Three doses of a recombinant DNA HBV vaccine (MSD) were given to healthy male homosexuals. Seventy-eight out of 104 (77.6%) participants had detectable antibody (anti-HBs) two months after the third dose. Seroconversion occurred in only 9 out of 27 subjects (33.3%) who were anti-HIV positive compared with 69 out of 77 (89.6%) who were negative (chi 2 = 30.8; P less than .001). Fifteen of the 18 anti-HIV positive who did not mount an antibody response to the hepatitis B vaccine (anti-HBs) later progressed to persistent generalised lymphadenopathy syndrome (5), AIDS-related complex (5), and AIDS (5). Only one of the nine anti-HIV positive anti-HBs responders developed PGL (chi 2 = 10.14; P less than .005). Our results show that anti-HIV positive homosexuals are poor responders to the recombinant hepatitis B vaccine and anti-HIV positive non-responders are more likely to develop clinically apparent HIV infection.


Subject(s)
HIV Seropositivity/immunology , Viral Hepatitis Vaccines/immunology , Follow-Up Studies , Hepatitis B/prevention & control , Hepatitis B Antibodies/biosynthesis , Hepatitis B Vaccines , Homosexuality , Humans , Male , Prognosis , Saccharomyces cerevisiae , Vaccines, Synthetic/immunology
6.
BMJ ; 298(6666): 80-2, 1989 Jan 14.
Article in English | MEDLINE | ID: mdl-2493302

ABSTRACT

OBJECTIVE: To determine the effect of low dose interferon alfa (human lymphoblastoid interferon) on aminotransferase activities in chronic non-A non-B hepatitis. DESIGN: Prospective randomised controlled parallel group study of active treatment versus no treatment carried out over 16 weeks and preceded by baseline measurements at weeks 8 and 4 and time zero. SETTING: HEPATOLOGY outpatient clinics in secondary referral centres. PATIENTS: Fourteen adults with histologically proved chronic hepatitis and persistently raised aminotransferase activities for six months or more. INTERVENTIONS: Seven patients randomised to receive interferon alfa 5 megaunits (MU) daily for one week, reducing to 5 MU thrice weekly for seven weeks, then 3 MU thrice weekly for eight weeks. Controls not treated. END POINT: Control of hepatic enzyme activity in chronic non-A non-B hepatitis. MEASUREMENTS AND MAIN RESULTS: Serum aspartate aminotransferase activity remained raised in controls (mean increase in study period 23.4 U/l) but fell rapidly to normal in the treated group (mean decrease 106.4 U/l). In four cases values were normal by eight weeks and in five cases by 16 weeks. Only minor side effects were recorded (fever, myalgia), which became less common as treatment progressed. CONCLUSIONS: Continuous low dose interferon alfa reduces aspartate aminotransferase activity to normal in most patients with chronic non-A non-B hepatitis and may prevent progression to cirrhosis.


Subject(s)
Hepatitis C/therapy , Hepatitis, Viral, Human/therapy , Interferon Type I/therapeutic use , Adult , Aspartate Aminotransferases/blood , Chronic Disease , Clinical Trials as Topic , Female , Hepatitis C/enzymology , Humans , Interferon Type I/administration & dosage , Male , Middle Aged , Prospective Studies , Random Allocation , Recombinant Proteins
8.
J Med Virol ; 21(1): 97-9, 1987 Jan.
Article in English | MEDLINE | ID: mdl-3491874

ABSTRACT

Suramin has recently been shown to inhibit the activity of the duck hepatitis B virus DNA polymerase (DHBV DNAp) in vitro. However, we found no demonstrable in vivo suppression of human hepatitis B virus DNA polymerase (HBV DNAp) activity in three male patients with severe chronic active hepatitis. Suramin treatment resulted in prolongation of the prothrombin time in all cases and a rise in bilirubin in two and it may have led to haemorrhage from oesophageal varices in one patient and to hepatic encephalopathy in another. Its use in chronic hepatitis is not recommended.


Subject(s)
Hepatitis B/drug therapy , Hepatitis, Chronic/drug therapy , Suramin/therapeutic use , Esophageal and Gastric Varices/complications , Gastrointestinal Hemorrhage/etiology , Hepatic Encephalopathy/chemically induced , Hepatitis B virus/enzymology , Humans , Male , Middle Aged , Nucleic Acid Synthesis Inhibitors , Pilot Projects , Suramin/adverse effects , Viral Proteins/antagonists & inhibitors
9.
J Immunol Methods ; 7(2-3): 251-4, 1975 Jun.
Article in English | MEDLINE | ID: mdl-1095655

ABSTRACT

Coupling of IgG anti-immunoglobulin to polystyrene bottles with carbodiimide has been used to bind selectively pig lymphocytes previously treated with anti-immunoglobulin or anti-Ig class-specific fluorescent conjugates. Subsequent recovery of the bound cells produced populations with approximately 80% of cells stained for surface Ig and 90% viability.


Subject(s)
Lymphocytes/immunology , Receptors, Antigen, B-Cell/analysis , Animals , Carbodiimides , Cell Separation , Cells, Cultured , Fluorescent Antibody Technique , Immune Sera , Immunoglobulin G , Methods , Polystyrenes , Swine
SELECTION OF CITATIONS
SEARCH DETAIL
...